BioInvent International AB Capital Reinvestment Ratio

Latest as of June 2025: 0.02x

BioInvent International AB capital reinvestment ratio. BioInvent International AB (BINV) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow (Skr66.78 Million) in capital expenditures (Skr1.38 Million). Check BioInvent International AB total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

Skr66.78 Million
SEK

Capital Expenditures

Skr1.38 Million
SEK

Data as of

Jun 2025
Most recent filing

Capital Reinvestment Ratio of BioInvent International AB (2007–2008)

Capital reinvestment ratio of BioInvent International AB from 2007 to 2008. This chart tracks BioInvent International AB's Capital Reinvestment Ratio across 2 annual periods. Also explore BINV net assets growth trend to track the company's year-over-year net asset growth rate.

BioInvent International AB Capital Reinvestment Ratio by Year (2007–2008)

BioInvent International AB capital reinvestment ratio by year from 2007 to 2008. For the full cash flow conversion analysis, see BINV cash flow metrics.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
2008 0.31x Skr43.73 Million Skr13.64 Million ▲ +0.8%
2007 0.31x Skr12.63 Million Skr3.91 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow